Location: San Francisco, CA
CIK: 0001056807 · Show all filings
Period: Q2 2020 (← Previous) (Next →)
Filing Date: Aug 14, 2020
Total Value: $1.622B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | SPRINGWORKS THERAPEUTICS INC | 2,286,891 | $96.05M | 5.9% | — | — | COM | 85205L107 |
| — | PRINCIPIA BIOPHARMA INC | 1,484,674 | $88.77M | 5.5% | — | — | COM | 74257L108 |
| ARGX | ARGENX SE | 390,000 | $87.84M | 5.4% | — | — | SPONSORED ADR | 04016X101 |
| IONS | IONIS PHARMACEUTICALS INC | 1,422,842 | $83.89M | 5.2% | — | — | COM | 462222100 |
| — | MERUS N V | 5,090,571 | $81.91M | 5.0% | — | — | COM | N5749R100 |
| XOMA | XOMA CORP DEL | 4,026,157 | $79.56M | 4.9% | — | — | COM NEW | 98419J206 |
| ACIU | AC IMMUNE SA | 11,318,758 | $76.17M | 4.7% | — | — | SHS | H00263105 |
| XNCR | XENCOR INC | 2,068,098 | $66.99M | 4.1% | — | — | COM | 98401F105 |
| — | REPARE THERAPEUTICS INC | 1,944,546 | $60.32M | 3.7% | — | — | COM | 760273102 |
| REPL | REPLIMUNE GROUP INC | 2,315,053 | $57.53M | 3.5% | — | — | COM | 76029N106 |
| — | FIVE PRIME THERAPEUTICS INC | 7,988,053 | $48.73M | 3.0% | — | — | COM | 33830X104 |
| RCUS | ARCUS BIOSCIENCES INC | 1,882,722 | $46.58M | 2.9% | — | — | COM | 03969F109 |
| IDYA | IDEAYA BIOSCIENCES INC | 3,226,769 | $45.85M | 2.8% | — | — | COM | 45166A102 |
| KURA | KURA ONCOLOGY INC | 2,775,882 | $45.25M | 2.8% | — | — | COM | 50127T109 |
| XENE | XENON PHARMACEUTICALS INC | 3,516,851 | $44.1M | 2.7% | — | — | COM | 98420N105 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 2,367,288 | $41.81M | 2.6% | — | — | COM | 74366E102 |
| — | CALITHERA BIOSCIENCES INC | 7,090,638 | $37.44M | 2.3% | — | — | COM | 13089P101 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 2,470,678 | $36.62M | 2.3% | — | — | COM | 87164F105 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 2,740,000 | $35.62M | 2.2% | — | — | COM NEW | 15117B202 |
| — | MOLECULAR TEMPLATES INC | 2,149,057 | $29.64M | 1.8% | — | — | COM | 608550109 |
| ANAB | ANAPTYSBIO INC | 1,294,401 | $28.92M | 1.8% | — | — | COM | 032724106 |
| — | GLYCOMIMETICS INC | 7,244,262 | $27.24M | 1.7% | — | — | COM | 38000Q102 |
| IMVT | IMMUNOVANT INC | 1,088,479 | $26.5M | 1.6% | — | — | COM | 45258J102 |
| CTMX | CYTOMX THERAPEUTICS INC | 3,115,537 | $25.95M | 1.6% | — | — | COM | 23284F105 |
| RVMD | REVOLUTION MEDICINES INC | 798,286 | $25.2M | 1.6% | — | — | COM | 76155X100 |
| — | SELECTA BIOSCIENCES INC | 8,294,547 | $23.56M | 1.5% | — | — | COM | 816212104 |
| — | SUTRO BIOPHARMA INC | 2,368,392 | $18.38M | 1.1% | — | — | COM | 869367102 |
| OVID | OVID THERAPEUTICS INC | 2,392,151 | $17.63M | 1.1% | — | — | COM | 690469101 |
| — | CALLIDITAS THERAPEUTICS AB | 750,000 | $17.48M | 1.1% | — | — | SPONSORED ADS | 13124Q106 |
| — | MEI PHARMA INC | 4,130,162 | $17.06M | 1.1% | — | — | COM NEW | 55279B202 |
| BDTX | BLACK DIAMOND THERAPEUTICS INC | 378,788 | $15.97M | 1.0% | — | — | COM | 09203E105 |
| INFIQ | INFINITY PHARMACEUTICALS INC | 17,426,968 | $15.76M | 1.0% | — | — | COM | 45665G303 |
| — | FORTE BIOSCIENCES INC | 978,857 | $14.27M | 0.9% | — | — | COM | 34962G109 |
| — | CIDARA THERAPEUTICS INC | 3,689,203 | $13.61M | 0.8% | — | — | COM | 171757107 |
| — | SURFACE ONCOLOGY INC | 2,038,528 | $13.37M | 0.8% | — | — | COM | 86877M209 |
| — | ESSA PHARMA INC | 1,984,889 | $12.31M | 0.8% | — | — | COM NEW | 29668H708 |
| PHAT | PHATHOM PHARMACEUTICALS INC | 322,098 | $10.6M | 0.7% | — | — | COM | 71722W107 |
| — | CONTRAFECT CORP | 1,600,000 | $10.22M | 0.6% | — | — | COM | 212326300 |
| — | GAMIDA CELL LTD | 2,143,667 | $9.797M | 0.6% | — | — | SHS | M47364100 |
| — | PIERIS PHARMACEUTICALS INC | 3,115,382 | $9.658M | 0.6% | — | — | COM | 720795103 |
| — | X4 PHARMACEUTICALS INC | 1,010,892 | $9.422M | 0.6% | — | — | COM | 98420X103 |
| — | VERASTEM INC | 5,028,994 | $8.65M | 0.5% | — | — | COM | 92337C104 |
| — | GALMED PHARMACEUTICALS LTD | 1,799,694 | $8.603M | 0.5% | — | — | SHS | M47238106 |
| — | CTI BIOPHARMA CORP | 6,929,690 | $8.038M | 0.5% | — | — | COM | 12648L601 |
| SPRO | SPERO THERAPEUTICS INC | 486,540 | $6.583M | 0.4% | — | — | COM | 84833T103 |
| — | EVELO BIOSCIENCES INC | 1,300,000 | $6.37M | 0.4% | — | — | COM | 299734103 |
| — | ERYTECH PHARMA | 625,000 | $5.263M | 0.3% | — | — | SPONSORED ADR | 29604W108 |
| CRVS | CORVUS PHARMACEUTICALS INC | 1,742,112 | $4.739M | 0.3% | — | — | COM | 221015100 |
| GNCAQ | GENOCEA BIOSCIENCES INC | 2,018,398 | $4.642M | 0.3% | — | — | COM NEW | 372427401 |
| — | CURIS INC | 3,650,000 | $4.417M | 0.3% | — | — | COM NEW | 231269200 |
| — | FORWARD PHARMA A/S | 647,299 | $3.968M | 0.2% | — | — | SPONSORD ADS NEW | 34986J204 |
| — | BIOLINERX LTD | 1,686,375 | $2.884M | 0.2% | — | — | SPONSORED ADS | 09071M205 |
| — | SPRING BK PHARMACEUTICALS INC | 941,171 | $1.384M | 0.1% | — | — | COM | 849431101 |
| — | REGULUS THERAPEUTICS INC | 1,450,000 | $988K | 0.1% | — | — | COM NEW | 75915K200 |
| — | NOVUS THERAPEUTICS INC | 1,785,000 | $818K | 0.1% | — | — | COM | 67011N105 |
| — | SUNESIS PHARMACEUTICALS INC | 2,594,925 | $684K | 0.0% | — | — | COM | 867328700 |
| EXEL | EXELIXIS INC | 15,300 | $363K | 0.0% | — | — | COM | 30161Q104 |